KalVista Pharmaceuticals (NasdaqGM:KALV) 2025 Conference Transcript

KalVista Pharmaceuticals (NasdaqGM:KALV) 2025 Conference November 19, 2025 08:30 AM ET Company ParticipantsBenjamin Palleiko - CEO and DirectorConference Call ParticipantsMaury Raycroft - Equity Research Analyst,Maury RaycroftHi, everyone. My name is Maury Raycroft. I'm one of the biotech analysts at Jefferies. I'm happy to introduce Ben Palleiko, the CEO of KalVista. It's a fireside chat format. Thanks so much for joining us today, Ben.Benjamin PalleikoMaury, thanks as always for the invite, and grateful t ...